Fonar (FONR) Competitors $15.83 -0.11 (-0.69%) As of 09:37 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. DCTH, BFLY, TMCI, RXST, SNWV, NPCE, STIM, CATX, CLPT, and OMShould you be buying Fonar stock or one of its competitors? The main competitors of Fonar include Delcath Systems (DCTH), Butterfly Network (BFLY), Treace Medical Concepts (TMCI), RxSight (RXST), Sanuwave Health (SNWV), NeuroPace (NPCE), Neuronetics (STIM), Perspective Therapeutics (CATX), ClearPoint Neuro (CLPT), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. Fonar vs. Its Competitors Delcath Systems Butterfly Network Treace Medical Concepts RxSight Sanuwave Health NeuroPace Neuronetics Perspective Therapeutics ClearPoint Neuro Outset Medical Fonar (NASDAQ:FONR) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends. Does the media favor FONR or DCTH? In the previous week, Delcath Systems had 6 more articles in the media than Fonar. MarketBeat recorded 7 mentions for Delcath Systems and 1 mentions for Fonar. Delcath Systems' average media sentiment score of 0.88 beat Fonar's score of 0.67 indicating that Delcath Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fonar 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Delcath Systems 0 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in FONR or DCTH? 50.6% of Fonar shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 1.6% of Fonar shares are held by insiders. Comparatively, 17.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is FONR or DCTH more profitable? Fonar has a net margin of 8.19% compared to Delcath Systems' net margin of 3.18%. Delcath Systems' return on equity of 8.63% beat Fonar's return on equity.Company Net Margins Return on Equity Return on Assets Fonar8.19% 5.31% 3.97% Delcath Systems 3.18%8.63%6.95% Do analysts recommend FONR or DCTH? Delcath Systems has a consensus price target of $24.50, indicating a potential upside of 142.21%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts plainly believe Delcath Systems is more favorable than Fonar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fonar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, FONR or DCTH? Fonar has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Which has preferable earnings and valuation, FONR or DCTH? Fonar has higher revenue and earnings than Delcath Systems. Fonar is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFonar$103.02M0.95$10.57M$1.2512.66Delcath Systems$37.21M9.47-$26.39M$0.05202.30 SummaryDelcath Systems beats Fonar on 11 of the 16 factors compared between the two stocks. Get Fonar News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFonarMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$98.75M$10.35B$5.42B$9.56BDividend YieldN/A2.02%3.99%4.14%P/E Ratio12.7419.2529.9025.14Price / Sales0.9523.10372.1776.15Price / Cash5.1821.8135.9458.58Price / Book0.642.848.105.59Net Income$10.57M$211.77M$3.26B$265.48M7 Day Performance1.21%1.54%0.65%1.22%1 Month Performance1.54%2.31%2.43%0.39%1 Year Performance-6.22%-11.48%27.70%23.47% Fonar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFonar1.4907 of 5 stars$15.83-0.7%N/A-5.4%$98.75M$103.02M12.74480DCTHDelcath Systems3.0541 of 5 stars$11.27+6.4%$24.00+113.0%+30.8%$368.81M$37.21M-22.5460News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpBFLYButterfly Network2.3835 of 5 stars$1.43+1.8%$3.50+145.6%+50.0%$346.20M$82.06M-5.09460Earnings ReportGap UpTMCITreace Medical Concepts2.5022 of 5 stars$5.61+5.1%$10.52+87.5%-12.6%$335.83M$209.36M-6.60250News CoverageEarnings ReportRXSTRxSight3.2944 of 5 stars$7.92+1.5%$17.50+121.0%-83.2%$316.97M$139.93M-11.82220Trending NewsEarnings ReportAnalyst ForecastSNWVSanuwave Health2.2969 of 5 stars$35.49-2.1%$49.00+38.1%N/A$310.55M$36.19M-7.7940News CoverageEarnings ReportGap UpNPCENeuroPace2.7253 of 5 stars$8.93-0.7%$17.00+90.4%+34.1%$294.86M$79.91M-10.63170Upcoming EarningsSTIMNeuronetics1.1596 of 5 stars$4.66+5.4%$5.50+18.0%+114.4%$292.22M$74.89M-3.56180Earnings ReportAnalyst ForecastCATXPerspective Therapeutics2.5296 of 5 stars$3.89+5.7%$12.56+222.8%-68.7%$288.75MN/A0.0070Upcoming EarningsCLPTClearPoint Neuro2.834 of 5 stars$10.53+5.3%$19.67+86.8%+69.6%$279.89M$31.39M-13.86110Positive NewsUpcoming EarningsGap DownOMOutset Medical1.8414 of 5 stars$14.16-5.9%$29.50+108.3%-72.2%$266.54M$113.69M-0.49520News CoverageAnalyst ForecastGap Up Related Companies and Tools Related Companies Delcath Systems Competitors Butterfly Network Competitors Treace Medical Concepts Competitors RxSight Competitors Sanuwave Health Competitors NeuroPace Competitors Neuronetics Competitors Perspective Therapeutics Competitors ClearPoint Neuro Competitors Outset Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fonar Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Fonar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
